Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population-Reference-Cited by-同舟云学术

Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population

Published:2019-02-01 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Gallardo-Alvarado Lenny N.,Tusié-Luna María Teresa,Tussié-Luna María Isabel,Díaz-Chávez José,Segura Yayoi X.,Bargallo-Rocha Enrique,Villarreal Cynthia,Herrera-Montalvo Luis A.,Herrera-Medina Enrique M.,Cantu-de Leon David F.^ORCID

Funder

DGAPA-UNAM

CONACYT

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5312-2.pdf

Reference59 articles.

1. WHO | Women’s health. WHO. 2016; Date accessed: 2016-10-04.

2. Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136(5):E359–86 Date accessed:2016-09-05.

3. Shannon KM, Chittenden A. Genetic testing by cancer site - breast. Cancer J. 2012;18(4):310–9.

4. Ripperger T, Gadzicki D, Meindl A, Schlegelberger B. Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet. 2009 Jun;17(6):722–31.

5. Vanags A, Strumfa I, Gardovskis A, Borošenko V, Aboliņš A, Teibe U, et al. Population screening for hereditary and familial cancer syndromes in Valka district of Latvia. Hered Cancer Clin Pract. 2010;8(1):8.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome;European Journal of Cancer;2024-11

2. Low prevalence of germline TP53 and PALB2 mutations in unselected cohort of breast cancer patients from Brunei Darussalam;F1000Research;2023-11-30

3. Germline TP53 pathogenic variants and breast cancer: A narrative review;Cancer Treatment Reviews;2023-03

4. Distinct NSCLC EGFR Variants in a Family With Li-Fraumeni Syndrome: Case Report;JTO Clinical and Research Reports;2022-08

5. Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients;Journal of Genetics and Genomics;2022-07